Literature DB >> 7618975

Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. A review.

A Recht1, M J Houlihan.   

Abstract

OBJECTIVE: The authors determined whether some patients with clinical stage I or II invasive breast cancer can be adequately treated by conservative surgery without radiotherapy. SUMMARY BACKGROUND DATA: Currently, there are many patients who are being treated in this manner in both academic and community hospitals. This approach is not as effective as either mastectomy or conservative surgery followed by radiotherapy in preventing local recurrence. However, there may be subsets of patients who might be adequately treated by surgery alone with acceptably low recurrence rates.
METHODS: The authors reviewed retrospective studies of conservative surgery alone and of randomized trials comparing the results of treatment with and without postoperative radiotherapy.
RESULTS: The local recurrence rate is unacceptably high when random patients are treated with conservative surgery without radiotherapy. More favorable results may be possible when relatively wide excisions are performed on selected postmenopausal patients with small lesions without an extensive intraductal component, lymphatic or blood-vessel invasion, and histologically negative axillary nodes. The role of tamoxifen in reducing the risk of breast recurrence is uncertain. Despite salvage therapy, some individuals may develop disseminated disease as a result of local recurrence.
CONCLUSIONS: The authors believe that conducting carefully designed prospective studies of conservative surgery alone is reasonable for patients who are adequately informed of the potential risks of omitting radiation therapy. However, currently, patients should not be treated with conservative surgery alone (without radiotherapy) without such stringent guidelines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7618975      PMCID: PMC1234749          DOI: 10.1097/00000658-199507000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  35 in total

Review 1.  Processing and evaluation of breast excision specimens. A clinically oriented approach.

Authors:  S J Schnitt; J L Connolly
Journal:  Am J Clin Pathol       Date:  1992-07       Impact factor: 2.493

2.  Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy.

Authors:  C C Cajucom; T N Tsangaris; T Nemoto; D Driscoll; R B Penetrante; E D Holyoke
Journal:  Cancer       Date:  1993-03-01       Impact factor: 6.860

3.  Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer.

Authors:  S M Pierce; A Recht; T I Lingos; A Abner; F Vicini; B Silver; A Herzog; J R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

Review 4.  Lumpectomy for breast cancer: an update of the NSABP experience. National Surgical Adjuvant Breast and Bowel Project.

Authors:  B Fisher; C Redmond
Journal:  J Natl Cancer Inst Monogr       Date:  1992

5.  Follow-up of two treatment modalities for ductal cancer in situ of the breast.

Authors:  L G Arnesson; S Smeds; G Fagerberg; O Gröntoft
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

Review 6.  Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.

Authors:  M S Anscher; P Jones; L R Prosnitz; W Blackstock; M Hebert; R Reddick; A Tucker; R Dodge; G Leight; J D Iglehart
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

7.  Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.

Authors:  G Liljegren; L Holmberg; H O Adami; G Westman; S Graffman; J Bergh
Journal:  J Natl Cancer Inst       Date:  1994-05-04       Impact factor: 13.506

8.  Segmental mastectomy without radiotherapy. Short-term follow-up.

Authors:  M D Lagios; V E Richards; M R Rose; E Yee
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

9.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.

Authors:  B Fisher; C Redmond; R Poisson; R Margolese; N Wolmark; L Wickerham; E Fisher; M Deutsch; R Caplan; Y Pilch
Journal:  N Engl J Med       Date:  1989-03-30       Impact factor: 91.245

10.  Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity.

Authors:  E R Fisher; R Sass; B Fisher; R Gregorio; R Brown; L Wickerham
Journal:  Cancer       Date:  1986-05-01       Impact factor: 6.860

View more
  4 in total

1.  Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT).

Authors:  Bruce G Haffty; Sharad Goyal; Diptee Kulkarni; Camille Green; Alexi Vazquez; Devora Schiff; Meena S Moran; Qifeng Yang; Shridar Ganesan; Kim M Hirsfield
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

Review 2.  Update on accelerated partial-breast irradiation.

Authors:  Alphonse G Taghian; Abram Recht
Journal:  Curr Oncol Rep       Date:  2006-01       Impact factor: 5.075

3.  Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy.

Authors:  Adedayo A Onitilo; Jessica M Engel; Rachel V Stankowski; Suhail A R Doi
Journal:  Clin Med Res       Date:  2014-12-08

4.  Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT).

Authors:  Hasan H Danish; Sharad Goyal; Neil K Taunk; Hao Wu; Meena S Moran; Bruce G Haffty
Journal:  Breast J       Date:  2013-03-26       Impact factor: 2.431

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.